Cost-effectiveness of COVID-19 vaccination in low- and middle-income countries.

ABSTRACT:

Background

Despite the advent of safe and effective COVID-19 vaccines, pervasive inequities in global vaccination persist.

Methods

We projected health benefits and donor costs of delivering vaccines for up to 60% of the population in 91 low- and middle-income countries (LMICs). We modeled a highly contagious (Re at model start = 1.7), low-virulence (IFR = 0.32%) "omicron-like" variant and a similarly contagious "severe" variant (IFR = 0.59%) over 360 days, accounting for country-specific age structure and healthcare capacity. Costs included vaccination startup (US$630 million) and per-person procurement and delivery (US$12.46/person vaccinated).

Results

In the omicron-like scenario, increasing current vaccination coverage to achieve at least 15% in each of the 91 LMIC

SUBMITTER: Siedner MJ 

PROVIDER: S-EPMC9214172 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature